Celldex Therapeutics Inc. (CLDX)

Celldex Therapeutics Inc. Azioni (CLDX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	172.31% 4.131	1.517	0.268	0.967	1.613
Operating Expenses	20.35% 51.46	42.76	33.47	33.44	29.40
Benefits Costs and Expenses	9.62% 38.65	42.76	33.47	33.44	28.10
Costs And Expenses	21.05% 51.76	42.76	33.47	33.44	29.50
Operating Income/Loss	15.49% -47.63	-41.24	-33.20	-32.47	-27.89
Income/Loss From Continuing Operations Before Tax	16.31% -34.51	-41.24	-30.50	-29.36	-26.49
Income/Loss From Continuing Operations After Tax	81.08% -7.239	-38.26	-30.50	-29.36	-9.003
Net Income/Loss	13.19% -43.31	-38.26	-30.50	-29.36	-26.49
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.45% 0.00121	0.0473	0.0473	0.0472	-46.76
Diluted Average Shares	97.45% 0.00121	0.0473	0.0473	0.0472	-46.76
Basic Earnings Per Share	3.70% -0.84	-0.81	-0.65	-0.62	-0.57
Diluted Earnings Per Share	3.70% -0.84	-0.81	-0.65	-0.62	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-